Skip to main content
Beginner 3 min read

Understanding Oncotype DX & Recurrence Scores

What Oncotype DX measures, how it is used to judge chemotherapy benefit, and what the TAILORx trial found.

NCI source:National Cancer Institute

Review status: AI-assisted, source checked. Not reviewed by a clinician. How we check pages

The short answer

Oncotype DX looks at the activity of 21 genes in breast tumor tissue to help predict whether chemotherapy is likely to work. In TAILORx, about 70% of women with this type of breast cancer could avoid chemotherapy based on risk scoring.

  • Oncotype DX looks at the activity of 21 genes in tumor tissue to help predict whether chemotherapy is likely to work.

  • In TAILORx, five-year invasive disease-free survival was 92.8% with hormone therapy alone versus 93.1% with chemotherapy added, a difference NCI reports as not statistically significant.

  • About 70% of women with hormone receptor-positive, HER2-negative breast cancer could avoid chemotherapy based on risk scoring.

  • For women 50 or younger with scores of 16 to 25, there may be a small benefit from chemotherapy.

Choose how you want to read this

The whole article, with every detail and caution.

This page is for people with early breast cancer who have an Oncotype DX result. It explains what the test measures, what the TAILORx trial found, and why the number alone decides nothing.

What the test measures

Oncotype DX is run on tumor tissue, not on a blood sample. NCI says it looks at the activity of 21 different genes to predict whether chemotherapy is likely to work for someone with breast cancer. It is not a scan. Ask your oncologist what your result means for you.

What TAILORx found

NCI reports that TAILORx enrolled 10,273 women at 1,182 sites in six countries. At five years, invasive disease-free survival was 92.8% with hormone therapy alone and 93.1% with hormone therapy plus chemotherapy. That difference was not statistically significant.

NCI says about 70% of women with hormone receptor-positive, HER2-negative breast cancer could avoid chemotherapy based on risk scoring.

There was one exception. For women 50 or younger with intermediate scores of 16 to 25, NCI says there may be a small benefit from chemotherapy. NCI advises these women to talk with their doctor.

Why the number alone decides nothing

Your oncologist reads the score alongside other facts about your cancer and your health. Trials have specific entry rules, and your situation may sit outside them. Writing down your questions before the visit can make that talk more useful.

If you have new symptoms or feel unwell while you wait, call your oncology team. Call 911 for an emergency.

Sources

Clinician holds a tablet toward a seated woman at a desk as they talk in a bright office.

Common questions

Does a high score mean my cancer has spread?

The test looks at gene activity in your tumor tissue. It is not a scan, so ask your oncologist what your result means for you.

What does Oncotype DX measure?

NCI says it looks at the activity of 21 different genes to predict whether chemotherapy is likely to work for someone with breast cancer.

My score is 18 and I am 46. What did TAILORx find for that?

NCI reports that for women 50 or younger with intermediate scores of 16 to 25, there may be a small benefit from chemotherapy. This is a specific discussion to have with your oncologist.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

More words from this kind of report

Other guides in biomarker & genetic tests.

Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Prepared by Cancer Explained's AI-assisted editorial system

Written from National Cancer Institute material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Written by: Cancer ExplainedSources last checked: 2026-07-30 what this meansLast updated: 2026-10-02Next planned review: 2027-07-30

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.